Exploring better strategies for EGFR antibodies in colon cancer.
INCLIVA Biomedical Research Institute, University of Valencia, Hospital Clínico de Valencia, Av Blasco Ibáñez, 17, 46010 Valencia, Spain. Electronic address: andres.cervantes@uv.es.
Andrés
A
Cervantes
D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab